Skip to main content
. 2021 Nov 18;13(11):1958. doi: 10.3390/pharmaceutics13111958

Figure 5.

Figure 5

DIC (a) and SEM (b) images of the optimized HbNPs formulation. FTIR (c) and CD (d) spectra of PLGA-NPs, free Hb and the optimized HbNPs. The HbNPs were prepared using 75 mg mL−1 Hb, 3 mg mL−1 PLGA, and 0.5% PVA.